COAGULATION FACTOR X HUMAN

1 FDA products 1 manufacturers

COAGULATION FACTOR X HUMAN is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as human prescription drug products.

About COAGULATION FACTOR X HUMAN

COAGULATION FACTOR X HUMAN appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Bio Products Laboratory Ltd. Approved labelling for these products most frequently references: coagulation factor, bleeding episodes, human plasma-derived, indicated adults, routine prophylaxis, on-demand treatment, perioperative management, mild moderate. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

Main manufacturers

ManufacturerProductsMarketing type
Bio Products Laboratory Ltd 1 HUMAN PRESCRIPTION DRUG

FDA drug products containing COAGULATION FACTOR X HUMAN

Brand nameManufacturerTypeRouteDosage form
Coagadex Bio Products Laboratory Ltd HUMAN PRESCRIPTION DRUG

Frequently asked questions

How many FDA drug products contain COAGULATION FACTOR X HUMAN?
1 FDA drug label records list COAGULATION FACTOR X HUMAN as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make COAGULATION FACTOR X HUMAN products?
The manufacturers with the most COAGULATION FACTOR X HUMAN label records are Bio Products Laboratory Ltd. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.